A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline

Affiliations

• ¹ Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain.
• ² Université Catholique de Louvain and de Duve Institute, Brussels, Belgium.
• ³ Ludwig Institute for Cancer Research, Brussels, Belgium.
• ⁴ WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Brussels, Belgium.
• ⁵ Hematology and Hemotherapy Department, Hospital Infantil Universitario Niño Jesús, Fundación para la investigación Biomédica HIUNJ, CIBERER, Madrid, Spain.
• ⁶ Haematology and Haemotherapy Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
• ⁷ Pathology Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain.
• ⁸ Université Catholique de Louvain and de Duve Institute, Brussels, Belgium. [email protected].
• ⁹ Ludwig Institute for Cancer Research, Brussels, Belgium. [email protected].
• ¹⁰ WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Brussels, Belgium. [email protected].
• ¹¹ Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC, Madrid, Spain. [email protected].